LINGRAPHICARE AMERICA, INC. FDA Inspection Record

FEI 1000123978 · Inspections, Form 483s, warning letters and import refusals

LINGRAPHICARE AMERICA, INC. is an FDA-registered facility (FEI 1000123978) located in PRINCETON, NJ, US. RegDataLab tracks 7 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Feb 3, 2025: Voluntary Action Indicated (VAI)
Inspections on record
7 (5 VAI, 2 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Feb 3, 2025Voluntary Action Indicated (VAI)Lack of or inadequate complaint procedures (21 CFR 820.198(a))
Design review - Lack of or inadequate procedures (21 CFR 820.30(e))
Design validation- Lack of or inadequate procedures (21 CFR 820.30(g))
Lack of or inadequate procedures (21 CFR 820.100(a))
and 2 more
Aug 4, 2022Voluntary Action Indicated (VAI)Lack of or inadequate complaint procedures (21 CFR 820.198(a))
Complaints (21 CFR 820.198(a))
Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a))
Lack of Written MDR Procedures (21 CFR 803.17)
Nov 15, 2019Voluntary Action Indicated (VAI)Lack of or inadequate complaint procedures (21 CFR 820.198(a))
Procedures not adequately established or maintained (21 CFR 820.40)
Training - Lack of or inadequate procedures (21 CFR 820.25(b))
Documentation (21 CFR 820.80(e))
and 3 more
Feb 15, 2017No Action Indicated (NAI)Procedures not adequately established or maintained (21 CFR 820.40)
Training - Lack of or inadequate procedures (21 CFR 820.25(b))
Lack of or inadequate final acceptance procedures (21 CFR 820.80(d))
Documentation (21 CFR 820.80(e))
Jun 24, 2014No Action Indicated (NAI)Design verification - output does not meet input requirement (21 CFR 820.30(f))
Design changes - Lack of or Inadequate Procedures (21 CFR 820.30(i))
Design validation - software validation not performed (21 CFR 820.30(g))
Dec 21, 2011Voluntary Action Indicated (VAI)Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a))
Documentation (21 CFR 820.100(b))
Apr 15, 2009Voluntary Action Indicated (VAI)Training - Lack of or inadequate procedures (21 CFR 820.25(b))
Lack of or inadequate receiving acceptance procedures (21 CFR 820.80(b))
Lack of or inadequate procedures (21 CFR 820.100(a))
DMR device specifications (21 CFR 820.181(a))
and 6 more

FDA record score

11 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

5 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIFeb 3, 20256 x 16
Inspection classified VAIAug 4, 20226 x 0.63.6
Inspection classified VAINov 15, 20196 x 0.251.5
Inspection classified VAIDec 21, 201110 years or older, so it adds no points0
Inspection classified VAIApr 15, 200910 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing LINGRAPHICARE AMERICA, INC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check LINGRAPHICARE AMERICA, INC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Lingraphicare America, Inc.
Location
PRINCETON, NJ (US)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.